Literature DB >> 33104215

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.

Kira Bona1, Ruta Brazauskas2,3, Naya He2, Leslie Lehmann4, Hisham Abdel-Azim5, Ibrahim A Ahmed6, A Samer Al-Homsi7, Mahmoud Aljurf8, Staci D Arnold9, Sherif M Badawy10,11, Minoo Battiwalla12, Sara Beattie13,14, Neel S Bhatt15, Jignesh Dalal16, Christopher E Dandoy17, Miguel Angel Diaz18, Haydar A Frangoul19, César O Freytes20, Siddhartha Ganguly21, Biju George22, David Gomez-Almaguer23, Theresa Hahn24, Rammurti T Kamble25, Jennifer M Knight26, C Fred LeMaistre12, Jason Law27, Hillard M Lazarus28, Navneet S Majhail29, Richard F Olsson30,31, Jaime Preussler32, Bipin N Savani33, Raquel Schears34, Sachiko Seo35, Akshay Sharma36, Alok Srivastava37, Amir Steinberg38, David Szwajcer39, Baldeep Wirk40, Ayami Yoshimi41, Nandita Khera42, William A Wood43, Shahrukh Hashmi44,45, Christine N Duncan4, Wael Saber2.   

Abstract

Social determinants of health, including poverty, contribute significantly to health outcomes in the United States; however, their impact on pediatric hematopoietic cell transplantation (HCT) outcomes is poorly understood. We aimed to identify the association between neighborhood poverty and HCT outcomes for pediatric allogeneic HCT recipients in the Center for International Blood and Marrow Transplant Research database. We assembled 2 pediatric cohorts undergoing first allogeneic HCT from 2006 to 2015 at age ≤18 years, including 2053 children with malignant disease and 1696 children with nonmalignant disease. Neighborhood poverty exposure was defined a priori per the US Census definition as living in a high-poverty ZIP code (≥20% of persons below 100% federal poverty level) and used as the primary predictor in all analyses. Our primary outcome was overall survival (OS), defined as the time from HCT until death resulting from any cause. Secondary outcomes included relapse and transplantation-related mortality (TRM) in malignant disease, acute and chronic graft-versus-host disease, and infection in the first 100 days post-HCT. Among children undergoing transplantation for nonmalignant disease, neighborhood poverty was not associated with any HCT outcome. Among children undergoing transplantation for malignant disease, neighborhood poverty conferred an increased risk of TRM but was not associated with inferior OS or any other transplantation outcome. Among children with malignant disease, a key secondary finding was that children with Medicaid insurance experienced inferior OS and increased TRM compared with those with private insurance. These data suggest opportunities for future investigation of the effects of household-level poverty exposure on HCT outcomes in pediatric malignant disease to inform care delivery interventions.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 33104215      PMCID: PMC7845011          DOI: 10.1182/blood.2020006252

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  41 in total

Review 1.  Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project.

Authors:  Nancy Krieger; Jarvis T Chen; Pamela D Waterman; Mah-Jabeen Soobader; S V Subramanian; Rosa Carson
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

2.  Socioeconomic status in health research: one size does not fit all.

Authors:  Paula A Braveman; Catherine Cubbin; Susan Egerter; Sekai Chideya; Kristen S Marchi; Marilyn Metzler; Samuel Posner
Journal:  JAMA       Date:  2005-12-14       Impact factor: 56.272

3.  Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010).

Authors:  Kira Bona; Traci M Blonquist; Donna S Neuberg; Lewis B Silverman; Joanne Wolfe
Journal:  Pediatr Blood Cancer       Date:  2016-02-23       Impact factor: 3.167

4.  Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation.

Authors:  S Fu; L Rybicki; D Abounader; S Andresen; B J Bolwell; R Dean; A Gerds; B K Hamilton; R Hanna; B T Hill; D Jagadeesh; M E Kalaycio; H D Liu; B Pohlman; R M Sobecks; N S Majhail
Journal:  Bone Marrow Transplant       Date:  2015-07-20       Impact factor: 5.483

5.  Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant.

Authors:  Suhag H Parikh; Prakash Satwani; Kwang Woo Ahn; Natasha A Sahr; Caitrin Fretham; Allistair A Abraham; Vaibhav Agrawal; Jeffery J Auletta; Hisham Abdel-Azim; Edward Copelan; Miguel-Angel Diaz; Christopher C Dvorak; Haydar A Frangoul; Cesar O Freytes; Shahinaz M Gadalla; Robert Peter Gale; Biju George; Usama Gergis; Shahrukh Hashmi; Peiman Hematti; Gerhard C Hildebrandt; Amy K Keating; Hillard M Lazarus; Kasiani C Myers; Richard F Olsson; Timothy Prestidge; Seth J Rotz; Bipin N Savani; Evan B Shereck; Kirsten M Williams; Baldeep Wirk; Marcelo C Pasquini; Alison W Loren
Journal:  JAMA Pediatr       Date:  2019-05-06       Impact factor: 16.193

6.  Cumulative hardship and wellness of low-income, young children: multisite surveillance study.

Authors:  Deborah A Frank; Patrick H Casey; Maureen M Black; Ruth Rose-Jacobs; Mariana Chilton; Diana Cutts; Elizabeth March; Timothy Heeren; Sharon Coleman; Stephanie Ettinger de Cuba; John T Cook
Journal:  Pediatrics       Date:  2010-04-12       Impact factor: 7.124

7.  Factors affecting receipt of expensive cancer treatments and mortality: evidence from stem cell transplantation for leukemia and lymphoma.

Authors:  Jean M Mitchell; Elizabeth A Conklin
Journal:  Health Serv Res       Date:  2014-07-22       Impact factor: 3.402

8.  Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families.

Authors:  Kira Bona; Wendy B London; Dongjing Guo; Gregory Abel; Leslie Lehmann; Joanne Wolfe
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-23       Impact factor: 5.742

9.  Zip code caveat: bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas--the Public Health Disparities Geocoding Project.

Authors:  Nancy Krieger; Pamela Waterman; Jarvis T Chen; Mah-Jabeen Soobader; S V Subramanian; Rosa Carson
Journal:  Am J Public Health       Date:  2002-07       Impact factor: 9.308

10.  Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.

Authors:  Fatima Rodriguez; David J Maron; Joshua W Knowles; Salim S Virani; Shoutzu Lin; Paul A Heidenreich
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

View more
  5 in total

1.  Increasing access to allogeneic hematopoietic cell transplant: an international perspective.

Authors:  Vanderson Rocha; Giancarlo Fatobene; Dietger Niederwieser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics.

Authors:  Sanghee Hong; Navneet S Majhail
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 3.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

Authors:  Kirsten M Williams; Yoshihiro Inamoto; Annie Im; Betty Hamilton; John Koreth; Mukta Arora; Iskra Pusic; Jacqueline W Mays; Paul A Carpenter; Leo Luznik; Pavan Reddy; Jerome Ritz; Hildegard Greinix; Sophie Paczesny; Bruce R Blazar; Joseph Pidala; Corey Cutler; Daniel Wolff; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Paul J Martin; Gerard Socie; Stefanie Sarantopoulos
Journal:  Transplant Cell Ther       Date:  2021-03-02

4.  Parental limited English proficiency in pediatric stem cell transplantation: Clinical impact and health care utilization.

Authors:  Joanna M Robles; Jesse D Troy; Kristin M Schroeder; Paul L Martin; Thomas W LeBlanc
Journal:  Pediatr Blood Cancer       Date:  2021-06-09       Impact factor: 3.838

Review 5.  Social determinants of health and pediatric cancer survival: A systematic review.

Authors:  Yvette H Tran; Scott L Coven; Seho Park; Eneida A Mendonca
Journal:  Pediatr Blood Cancer       Date:  2022-02-02       Impact factor: 3.838

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.